HighTower Advisors
ADPT icon

HighTower Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

HighTower Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,648
Closed -$204K – 3651
2025
Q3 		$204K Sell
13,648
-3,274
-19% -$39.9K ﹤0.01% 3357
2025
Q2 		$197K Buy
16,922
+239
+1% +$2.17K ﹤0.01% 3296
2025
Q1 		$124K Sell
16,683
-25
-0.1% -$192 ﹤0.01% 3319
2024
Q4 		$100K Buy
16,708
+25
+0.1% +$138 ﹤0.01% 3371
2024
Q3 		$87K Hold
16,683
– – ﹤0.01% 3336
2024
Q2 		$60K Buy
16,683
+1,105
+7% +$3.51K ﹤0.01% 3279
2024
Q1 		$50K Sell
15,578
-801
-5% -$3.1K ﹤0.01% 3254
2023
Q4 		$80K Buy
16,379
+801
+5% +$3.65K ﹤0.01% 3238
2023
Q3 		$86K Hold
15,578
– – ﹤0.01% 3130
2023
Q2 		$105K Sell
15,578
-6,600
-30% -$49.1K ﹤0.01% 3060
2023
Q1 		$196K Sell
22,178
-5,525
-20% -$48.7K ﹤0.01% 2766
2022
Q4 		$213K Hold
27,703
– – ﹤0.01% 2724
2022
Q3 		$197K Sell
27,703
-113
-0.4% -$1.06K ﹤0.01% 2619
2022
Q2 		$226K Buy
27,816
+16,419
+144% +$144K ﹤0.01% 2547
2022
Q1 		$160K Buy
+11,397
New +$179K ﹤0.01% 2894
2021
Q4 		– Sell
-12,311
Closed -$418K – 3285
2021
Q3 		$418K Sell
12,311
-1,889
-13% -$68.3K ﹤0.01% 2183
2021
Q2 		$580K Sell
14,200
-1,470
-9% -$57.1K ﹤0.01% 1970
2021
Q1 		$631K Sell
15,670
-13,042
-45% -$706K ﹤0.01% 1834
2020
Q4 		$1.7M Buy
28,712
+8,012
+39% +$413K 0.01% 983
2020
Q3 		$1.01M Buy
20,700
+7,750
+60% +$326K ﹤0.01% 1214
2020
Q2 		$627K Sell
12,950
-14,250
-52% -$520K ﹤0.01% 1346
2020
Q1 		$756K Sell
27,200
-30,175
-53% -$842K ﹤0.01% 1143
2019
Q4 		$1.72M Buy
+57,375
New +$1.65M 0.01% 911

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HighTower Advisors's ADPT Position: Q4 2025 in Review

HighTower Advisors sold out of Adaptive Biotechnologies (ADPT) in Q4 2025, closing a stake of 13,648 shares — an estimated $204K sold.

HighTower Advisors first reported a position in ADPT in Q4 2019 and held it in 23 quarters. The position peaked at $1.72M in Q4 2019. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • HighTower Advisors reported no remaining Adaptive Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • HighTower Advisors sold 13,648 Adaptive Biotechnologies shares in Q4 2025, an estimated $204K.
  • HighTower Advisors first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 23 quarters.
  • HighTower Advisors's Adaptive Biotechnologies position peaked at $1.72M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.